CLINICAL_TRIALS
trial_result
· 2020-09-07
Clinical Trial Update: Imaging Characteristics of a Follow-up 18F-AV-1451 Scan [Phase 2]
Summary
Phase 2 imaging study update for 18F-AV-1451 in Alzheimer's disease; study terminated with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Avid Radiopharmaceuticals | Conditions: Alzheimer's Disease | Phase 2 | Status: TERMINATED | Results posted: 2020-09-07